Open Versus Endovascular Revascularization in Patients With End-stage Renal Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

77 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-07-01

Study Completion Date

2017-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Treatment of patients with end-stage renal disease and critical limb ischemia still poses challenges to vascular medicine due to limited survival, comorbidities and infrapopliteal involvement of arteriosclerosis in these patients.

Most optimal vascular therapy mode has not been finally decided in these patients.

Therefore retrospective analysis of patients receiving open surgical and endovascular revascularisation was performed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cerebral Microembolism During Hemodialysis

NCT02021045

Complication of Dialysis Thrombus Due to Renal Dialysis Device, Implant, or Graft Cerebral Embolism

COMPLETED

Renal Denervation to Improve Outcomes in Patients With End-stage Renal Disease

NCT02021019

End-stage Renal Disease Hypertension

COMPLETED NA

Role and Outcome of Endovascular Revascularization of Chronic Limb Ischaemia

NCT05643378

Limb Ischemia, Critical

UNKNOWN

Arterial Calcifications in Nocturnal Hemodialysis and Renal Transplantation Versus Conventional Dialysis

NCT00950573

Kidney Disease

COMPLETED

Cessation of Dialysis Treatment in Reinbek and Geesthacht

NCT03820765

Complication of Renal Dialysis Long-Term Disorder of Dialysis

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Query of internal clinical database for identification of patients (2009-2017)with end-stage renal disease and critical limb ischemia, receiving either open surgical (Group I "OR") or endovascular revascularisation (Group II "EVT").

Furthermore, retrospective comparison as to morphological criteria (lesion length, peripheral run-off, plantar arch) and comorbidities.

Prospective follow-up of identified patients by means of telephone contacts and/or clinical examination of evaluation of Long-term outcome measures (Overall survival, Amputation-free survival, wound healing)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End-stage Renal Disease Critical Limb Ischemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

OR

patients treated with open revascularization

open revascularization

Intervention Type PROCEDURE

surgical revascularization (i.e. Bypass surgery)

EVT

patients treated with endovascular revascularization

endovascular revascularization

Intervention Type PROCEDURE

endovascular revascularization (stent, ballon angioplasty)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

open revascularization

surgical revascularization (i.e. Bypass surgery)

Intervention Type PROCEDURE

endovascular revascularization

endovascular revascularization (stent, ballon angioplasty)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* presence of end-stage renal disease
* presence of critical limb ischemia (Ankle-brachial-index \> 0.4 or presence of rest pain or ischemic ulcers or gangrene)
* revascularisation by means of Bypass or endovascular therapy